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We document a helper-independent reverse genetics system for rescuing infectious arenaviruses from cloned cDNAs. We constructed plasmids
containing full-length cDNAs of the antigenomic (ag) L and S segments of the Armstrong (ARM) strain of the prototypic Arenavirus lymphocytic
choriomeningitis virus (LCMV) flanked at their 5′- and 3′-termini by the T7 RNA polymerase (T7RP) promoter and ribozyme sequences,
respectively. These plasmids directed intracellular synthesis of viral L and S ag RNA species in cells expressing plasmid-supplied T7RP. Co-
expression of plasmid-supplied LCMV trans-acting factors, nucleoprotein (NP) and polymerase (L), resulted in replication and expression of L
and S ag and genome RNA species, and generation of LCMV infectious progeny termed rT7/LCMV. The recombinant rT7/LCMV was
unequivocally identified based on a genetic tag introduced in the recombinant S segment. In addition, rT7/LCMVexhibited growth and biological
properties predicted for an ARM-like LCMV. To our knowledge, this is the first documented Arenavirus rescue, as well as of an ambisense
negative strand (NS) RNA virus, entirely from cloned cDNAs. Our results extend the use of reverse genetic approaches for DNA-mediated virus
rescue to all known virus families with NS RNA genome.
© 2006 Elsevier Inc. All rights reserved.Keywords: Rescue; Lymphocytic choriomeningitis virus (LCMV); Arenavirus; Reverse geneticsIntroduction
Arenaviruses merit significant attention both as tractable
model systems to study acute and persistent viral infections,(de
la Torre and Oldstone, 1996; Oldstone, 2002; Zinkernagel,
2002) and as clinically important human pathogens including
several causative agents of severe, often lethal, hemorrhagic
fever (HF), like Lassa fever virus (LFV) (Buchmeier et al.,
2001; Geisbert and Jahrling, 2004; McCormick and Fisher-
Hoch, 2002; Peters, 2002). In addition, mounting evidence
indicates that the prototypic Arenavirus lymphocytic chorio-
meningitis virus (LCMV) might be a neglected human pathogen
of clinical significance (Buchmeier and Zajac, 1999; Jahrling
and Peters, 1992). Therefore, it is important to develop better
antiviral strategies to combat pathogenic arenaviruses, a task
that would be facilitated by a better understanding of the
Arenavirus molecular and cell biology.
LCMV is an enveloped virus with a bisegmented negative
single-stranded RNA genome and a life cycle restricted to the⁎ Corresponding author. Fax: +1 858 784 9981.
E-mail address: juanct@scripps.edu (J.C. de la Torre).
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doi:10.1016/j.virol.2006.01.012cell cytoplasm (Buchmeier and Zajac, 1999; Buchmeier et al.,
2001; Meyer et al., 2002; Salvato, 1993; Southern, 1996).
Each genomic RNA segment, L (ca 7.3 kb) and S (ca 3.4 kb),
uses an ambisense coding strategy to direct the synthesis of
two polypeptides in opposite orientation, separated by an
intergenic region (IGR) with a predicted folding of a stable
hairpin structure. The S RNA encodes the viral glycoprotein
precursor, GPC, (ca 75 kDa) and the nucleoprotein, NP, (ca
63 kDa), whereas the L RNA encodes the viral RNA
dependent RNA polymerase (RdRp, or L polymerase) (ca 200
kDa), and a small RING finger protein Z (ca 11 kDa). The
NP and L coding regions are transcribed into a genomic
complementary mRNA, whereas the GPC and Z coding
regions are translated from genomic sense mRNAs that are
transcribed using as templates the corresponding antigenome
RNA species. NP is the most abundant viral protein and
encapsidates viral genomes and antigenomic replicative
intermediates. The viral glycoprotein precursor GPC is
posttranslationally cleaved by the SKI-1/S1P cellular protease
to yield the two mature virion glycoproteins GP-1 (40–46
kDa) and GP-2 (35 kDa) (Beyer et al., 2003; Pinschewer et
al., 2003a, 2003b). Correct processing of GPC is required for
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et al., 2003; Pinschewer et al., 2003a, 2003b), which bud
from the plasma membrane (Dalton et al., 1968; Murphy et
al., 1970). Non-covalently associated GP1/GP2 complexes
make up the spikes on the virion envelope, and mediate virus
interaction with the host cell receptor and subsequent virus
cell entry via receptor mediated endocytosis (Cao et al., 1998;
Kunz et al., 2001, 2002). Arenavirus L proteins contain the
characteristic conserved A, B, C and D motifs within the
proposed catalytic domain III of the L polymerases of NS
RNA viruses (Poch et al., 1989). Using mutation-function
assays, we confirmed the key role on Arenavirus polymerase
activity of the highly conserved amino acid residues within
motifs A and C and provided both genetic and biochemical
evidence that oligomerization of L is required for its function
(Sanchez and de la Torre, 2005), a parallel finding to that
reported for the L protein of paramyxoviruses (Smallwood
and Moyer, 2004; Smallwood et al., 2002). The small (11
kDa) RING finger protein Z (Salvato et al., 1989, 1992)
functions as the Arenavirus counterpart of the matrix protein
found in many NS RNA viruses (Perez et al., 2003, 2004;
Strecker et al., 2003). Additional roles of Z in the Arenavirus
life cycle have been proposed based on its interaction with
several host cell proteins (Borden et al., 1997, 1998;
Campbell Dwyer et al., 2000), and its ability to inhibit
RNA synthesis mediated by the virus polymerase (Cornu and
de la Torre, 2001, 2002; Cornu et al., 2004; Hass et al., 2004;
Lopez et al., 2001).
The inability to genetically manipulate the virus genome
has hampered studies aimed at a detailed understanding of the
Arenavirus molecular and cell biology. As with other negative
strand (NS) RNA viruses, the template of the LCMV
polymerase is exclusively a nucleocapsid consisting of the
genomic RNA tightly encapsidated by the virus NP, which
associated with the virus polymerase proteins forms a
ribonucleoprotein (RNP) complex. This RNP is active in
transcription and replication and is the minimum unit of
infectivity (Conzelmann, 2004; Garcia-Sastre and Palese,
1993; Neumann et al., 2002; Tordo et al., 1992). In contrast
to positive-stranded RNA viruses, deproteinized genomic and
antigenomic RNAs of negative strand RNA viruses cannot
function as mRNAs and are not infectious. Thus, generation of
biologically active synthetic NS viruses from cDNA will
require trans complementation by all viral proteins involved in
virus replication and transcription. These considerations have
severely hindered the application of recombinant DNA
technology to the genetic analysis of these viruses. However,
during the last decade, following the pioneering work of
Palese's group (Luytjes et al., 1989), significant progress has
been made in this area and for many negative strand RNA
viruses, short model genomes could be encapsidated and
expressed either by infectious helper viruses or by plasmid-
encoded proteins. This approach has revolutionized the
analysis of cis-acting sequences and trans-acting proteins
required for virus replication, transcription, maturation and
budding (Conzelmann, 2004; Kawaoka, 2004; Neumann et al.,
2002). Moreover, it has allowed the generation and rescue ofinfectious viruses entirely from cloned cDNAs for members of
most families of NS RNA viruses (Conzelmann, 2004;
Kawaoka, 2004; Neumann et al., 2002; Schneider et al.,
2005), which has provided investigators with novel and
powerful approaches for the investigation of viral pathogen-
esis. In addition, these developments have also paved the way
for engineering these viruses for vaccine and gene therapy
purposes.
We have described a reverse genetic system for LCMV that
is suitable for the investigation of cis-acting signals and trans-
acting factors involved in virus RNA synthesis and gene
expression, as well as viral assembly and budding (Cornu and
de la Torre, 2001, 2002; Lee et al., 2000, 2002; Perez and de
la Torre, 2003; Perez et al., 2003; Pinschewer et al., 2003a,
2003b, 2005; Sanchez and de la Torre, 2005). Similar systems
have been now developed for LFV (Hass et al., 2004) and the
New World Arenavirus Tacaribe virus (TV) (Lopez et al.,
2001). In addition, we have documented the generation of a
recombinant LCMV (rLCMV/VSVG), where the glycoprotein
of vesicular stomatitis virus (VSVG) substituted for the
LCMV GP (Pinschewer et al., 2003a, 2003b, 2004). This
rLCMV was generated by intracellular reconstitution of a
recombinant LCMV S RNP via reverse genetics, and infection
with LCMV helper virus. Production of infectious LCMV, but
not of rLCMV/VSVG, required the correct processing of
LCMV GPC by the cellular protease S1P, which facilitated the
selection of rLCMV/VSVG by using S1P deficient cells. The
isolated rLCMV/VSVG has provided us with a powerful tool
to facilitate the isolation of LCM viruses containing
engineered rS segments. For this, cells instructed to express
the rS RNP of interest are infected with rLCMV/VSVG, and
the virus progeny is subjected to selection with a neutralizing
antibody to VSV G to eliminate the helper rLCMV/VSVG.
This approach however requires several rounds of selection,
and is limited to the rescue of LCMV carrying recombinant S
segments.
Here, we document the rescue of infectious LCMV,
Armstrong strain (LCMV-ARM), entirely from plasmid,
without the need of using a helper virus. Transfection of
cells with plasmids that directed T7RP-mediated intracellular
synthesis of L and S antigenomic (Lag and Sag) RNA
species, together with pol-II expression plasmids for the
T7RP and the viral trans-acting factors L and NP permitted
the rescue of a rLCMV called rT7/LCMV. Production of rT7/
LCMV was readily detected 72 h after transfection, which
was followed by a rapid increase in virus production reaching
titers of 107 PFU/ml. The rT7/LCMV was unequivocally
identified based on a genetic tag introduced in the re-
combinant S segment. In addition, rT7/LCMV exhibited
growth and biological properties predicted for an ARM-like
LCMV including: (1) induction of lethal choriomeningitis
(LCM) following intracranial inoculation (ic) of adult mice,
(2) induction of robust T-cell responses and (3) ability to
establish persistence upon infection of newborn mice. Our
findings extend the use of reverse genetic approaches for
DNA-mediated rescue of members of all known families with
NS RNA genome.
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Transcription and replication of antigenomic segments of LCMV
We generated constructs pT7-L(+)HR and pT7-S(+)HR (Fig.
1A) by inserting full-length cDNAs of the L and S, respectively,
segments of LCMV-ARM between the T7RP promoter (pT7)
and an LCMV-specific hairpin ribozyme. Both L and S full-
length cDNAs were obtained via RT-PCR using RNA isolatedFig. 1. LCMV polymerase mediated replication and transcription of plasmid supplie
RNA species. Plasmid pT7-S(+)HR and pT7-L(+)HR contain the following elements:
complete sequence of the S (pT7-S(+)HR) or L (pT7-L(+)HR) RNAs in antigenomic
ribozyme (HR), and (4) the sequence of T7 terminator (T7T). Plasmid pT7-L(+)HDR
after the 3′UTR, followed by hepatitis delta riboenzyme (HDR) sequence instead of
plasmid supplied Sag and Lag RNA species. BHK-21 cells (2.5 × 105/cm2) were tr
indicated amounts), pT7-S(+)HR (0.4 μg), pC-NP (0.4 μg) and pC-L (0.5 μg). Forty
each sample were analyzed by Northern blot hybridization using appropriate [32P] rUT
GP and Z mRNAs. (Bi) Predicted RNA species detected by Northern Blot hybridizatio
detected the Sag RNA and GP mRNA derived from pT7-S(+)HR , but failed to detec
probe readily detected the Lag RNA and Z mRNA derived from pT7-L(+)HDR.from purified LCMV-ARM virions, and cloned in an anti-
genomic (ag) polarity with respect to the T7p. The S cDNA
could be amplified in a single step, whereas the complete L
cDNA was amplified in two PCR products, one containing the
ag 5′-end and the L ORF, and the other containing a C-part of
the L ORF together with the L IGR, the Z ORF and the ag 3′-
end. Both PCR products overlap for sequences located within
the C-terminus of the L ORF to facilitate the generation of a
full-length L cDNA via ligation of the two initial PCRd ag S and L RNA species. (A) Schematics of plasmids encoding Sag and Lag
(1) a truncated T7RP promoter (pT7) lacking two G residues at its 3′-end, (2) the
polarity with respect to the pT7, (3) the sequence of an LCMV-specific hairpin
is a modification of pT7-L(+)HR where an additional C residue was introduced
the HR. (B) Analysis of transcription and replication by the virus polymerase of
ansfected with pC-T7 (1 μg), pT7-L(+)HR (1 μg) or pT7-L(+)HDV (using the
-eight-hour post transfection total cell RNAwas isolated and equal amounts of
P labeled RNA probes to detect the Lg, Lag, Sg and Sag RNA species, as well as
n using the indicated strand-specific probes. (Bii) The GP and Z antisense probes
t the Lag RNA and Z mRNA derived from pT7-L(+)HR. (Biii) The Z antisense
Fig. 2. Recovery of rT7/LCMV from cDNAS. (A) Schematic of the plasmid-
based rescue system. BHK-21 cells (106) were transfected with pC-T7 (2 μg),
pT7-L(+)HDR (2 μg), pT7-S(+)HR (1.3 μg), pC-NP (0.8 μg), pC-L (1 μg) and
pC-GP (0.4 μg). Three days later cells were transfer into T75 to expand them.
(B) Detection of infectious virus in the tissue culture supernatant (TCS) of
transfected cells. TCS were collected at days 3, 7 and 10 after transfection and
the presence of infectious virus examined by infection of BHK-21 cells and
detection of viral antigen by IF at 36 h pi.
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a defined nucleotide sequence for the L IGR (nucleotides 359 to
567, genome polarity). This was only possible by using a
thermo-stable RT to conduct RT-PCR at higher temperature and
in the presence of 5% DMSO. The corresponding PCR product
was cloned and nucleotide sequence of multiple clones
determined. We observed genetic heterogeneity among inde-
pendent clones, but no evidence of dominance of a specific
sequence. Several clones harbored large deletions that corre-
sponded to stem loop structures deleted during the amplification
or during the sequencing reaction by polymerase slippage.
Others have also reported deletions in the L IGR of LCMV
(Salvato et al., 1989; Shimomaye and Salvato, 1989) and LFV
(Vieth et al., 2004). Based on our sequence data, we derived a
consensus sequence for the L IGR (GenBank AY894816) that
differed from the previously published (Salvato et al., 1989), but
identical to one recently determined by Grande-Perez et al.
(Grande-Perez et al., 2005), and the one independently
determined by Whelan's group (GenBank AY894816).
The use of a truncated T7RP promoter, containing a single G,
directed T7RP-mediated synthesis of the L and S ag RNA
species with the correct 5′-termini including the non-templated
G residue found at the 5′-termini of Arenavirus genome and
antigenome RNA species. The generation of the authentic viral
3′-termini was mediated by an LCMV-specific hairpin ribo-
zyme (HR) inserted downstream to the 3′-UTR of the L and S
ag RNA, followed by a T7 terminator motif (T7T).
We first examined whether these constructs could direct
intracellular synthesis of S and L ag RNA species that could be
correctly encapsidated by plasmid supplied NP to generate a
nucleocapside template that could be replicated and transcribed by
the intracellularly reconstituted virus polymerase. We observed
that plasmid-supplied T7RP directed intracellular synthesis of Sag
and Lag RNA efficiently, and the Sag RNA was subsequently
replicated and transcribed by the virus polymerase as determined
by Northern blot using strand-specific riboprobes (Fig. 1B). In
contrast, the lack of hybridization signal with the Z antisense
riboprobe indicated that T7RP produced an Lag RNA that did not
serve as an efficient template for the generation of L genomic (Lg)
RNA, and subsequent Z mRNA synthesis, by the LCMV
polymerase (Fig. 1Bii). We reasoned that inefficient RNA self-
cleavage mediated by the HR resulted in low levels of correctly
processed 3′-termini of the Lag RNA, which interfered with
encapsidation or polymerase recognition, or both. To attempt
overcoming this problem, and based on our previous findings
(Perez and de la Torre, 2003), we generated the construct pT7-L
(+)HDV (Fig. 1A), where the HDV substituted for the HR
ribozyme. The LagRNAproduced via T7RP contained an extra C
at its 3′-end to improve the HDV-mediated Lag RNA processing
(Perez and de la Torre, 2003). This new construct directed the
intracellular synthesis of a Lag RNA that was efficiently
replicated into Lg RNA by the virus polymerase (Fig. 1Biii).
Rescue of LCMV from plasmid
We next attempt to rescue LCMV from plasmid (Fig. 2A). For
this, we transfected BHK-21 cells with plasmids expressing theSag and Lag RNA species together with pC-L and pC-NP, as well
as pC-T7, using optimized conditions that recreated ratios of L/S
G RNA and relative levels of GP and Z mRNA observed in
LCMV-infected cells (MOI = 0.1) at 48 h p.i. Three days post
transfection, we subcultured the cells to prevent the characteristic
deterioration of BHK-21 cells when left as confluent monolayers
for extended period of time. We examined tissue culture
supernatant (TCS) collected at days 3, 7 and 10 post transfection
for the presence of infectious LCMV by infecting fresh
monolayers of BHK-21 cells and detection 36 h later of viral
antigen by IF (Fig. 2B). Infectious virus was readily detected at
72 h after transfection, and titers grew up rapidly to 107 PFU/ml.
Similar results were obtained in several independent experiments.
Genetic characterization of rescued LCMV
To confirm the identity of the rT7/LCMV rescued from
cDNAwe took advantage of a genetic tag introduced into the S
cDNA. This tag consisted of a single silent mutation that
eliminated an Eco NI restriction site present within the S of
LCMV-ARM (Fig. 3A). We used RNA isolated from BHK-21
Fig. 3. Genetic characterization of rescued rT7LCMV. (A) Schematic of the
genetic tag introduced within the S segment. The genetic tag consisted of a silent
mutation (G to A) that resulted in the lost in the S segment of rT/LCMVof an
EcoNI site present in LCMV-ARM. (B) Detection of the genetic tag in the S
segment of rT7/LCMV. RNAwas isolated from BHK-21 cells infected with the
rescued rT7/LCMVand subjected to RT-PCR with primers to amplify a 520-bp
fragment containing the genetic tag. PCR products were subjected to restriction
analysis with EcoNI and the products analyzed by agarose (2%) gel
electrophoresis. PCR fragments derived from RNA isolated from LCMV-
ARM, but not from rT7/LCMV, infected cells were digested by EcoNI.
Sequence analysis of the PCR products confirmed that PCR products derived
from RNA isolated from LCMV-ARM or rT7/LCMV infected cells differed
only at the predicted site where the genetic tag was introduced.
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RT-PCR to amplify a segment of 520 bp that contained the
genetic tag. As predicted, PCR products derived from LCMV-
ARM, but not from rT7/LCMV, infected cells were susceptible
to digestion with Eco NI (Fig. 3B). Sequencing of the
corresponding PCR products confirmed that a single change
G to A in rT7/LCMV was responsible for the lost of the Eco NI
present in LCMV-ARM.
Growth properties of rT7/LCMV in cultured cells
We next compared the growth properties in cultured cells of
rT7/LCMV and LCMV/ARM. For this we infected BHK-21
cells (MOI = 0.1) with either rT7/LCMVor LCMV-ARM, and
determined levels of viral RNA and virus titers at different timesp.i. Both rT7/LCMV and LCMV/ARM exhibited similar
kinetics and levels of RNA replication and transcription as
determined by Northern blot hybridization using a NP DNA
probe that hybridized to the S RNA (replication) and NP mRNA
(transcription) (Fig. 4A). Likewise, both viruses had similar
kinetics and production peaks of infectious progeny (Fig. 4B).
Biological properties of rLCMV
To further corroborate that the experimental procedures used
for the rescue of rT7/LCMV did not result in unexpected
phenotypic viral properties we compared rT7/LCMV and
LCMV-ARM wt with respect to three well-characterized
biological features of LCMV: (1) its ability to induce lethal
lymphocytic choriomeningitis (LCM) upon intracranial (ic)
inoculation of adult mice, (2) its ability to induce a robust viral-
specific T-cell response upon inoculation (i.p.) of adult mice,
which results in subsequent viral clearance, and (3) its ability to
establish a persistent infection upon infection of newborn mice.
Both LCMV-ARM and rT7/LCMV induced lethal LCMwith
similar efficiency in infected (i.c.) adult B6 mice (Fig. 5A).
Accordingly, both rT7/LCMV and LCMV/ARM reached
similar infectious titers in brains and sera of infected mice
(Fig. 5B). EcoNI digestion of RT-PCR products derived from
RNA isolated from brains of infected mice confirmed the
genetic identity of the viruses and showed that reversion of rT/
LCMV to LCMV-ARM genotype was not required for
development of lethal LCM (Fig. 5C). Likewise, adult B6
mice infected (i.p.) with either rT7/LCMV or LCMV/ARM
developed CD8- and CD4-T cell responses of similar quality
and magnitude (Fig. 6) that resulted in undetectable virus titers
in serum at day 15 p.i. (not shown). Moreover, as documented
extensively for LCMV, newborn B6 mice infected with rT7/
LCMV developed a persistent infection as determined by the
presence of infectious virus (Fig. 7A) and RNA (Fig. 7B) in
brain and liver at day 21 p.i. Likewise, mice infected at birth
with either LCMV-ARM or rT7/LCMV had similar serum viral
load (Fig. 7A).
Discussion
The use of plasmids that direct intracellular synthesis of
positive-sense cRNA (antigenomic species) rather than the
negative-sense genomic vRNA appeared to facilitate the
rescue of a variety of cytoplasmic NS RNA viruses (Con-
zelmann, 2004; Kawaoka, 2004; Neumann et al., 2002). The
rationale behind this approach was that it would prevent
potential hybrid arrest effects due to annealing between
negative-sense vRNA and positive-sense mRNAs. In the
case of viruses with an ambisense gene organization, including
arenaviruses, both genome and antigenome RNA species
contain sequences complementary to one of the viral mRNAs
(Buchmeier et al., 2001; Meyer et al., 2002; Salvato, 1993;
Southern, 1996), which could pose special problems for the
cDNA-mediated rescue of these viruses. To minimize this
potential obstacle for the cDNA-mediated rescue of infectious
LCMV we used plasmids that expressed ag RNA species of
Fig. 4. Growth properties of rT7/LCMV. Vero cells were infected with LCMVARM or rT7/LCMV (both at MOI = 0.1). TCS and RNAwere harvested at 0, 12, 24, and
48 h p.i. (A) RNA was analyzed by Northern Blot hybridization using a 32P-labeled NP DNA probe that hybridizes to both NP mRNA (transcription) and S RNA
(replication). (B) Viral titers in TCS were determined by plaque assay.
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plasmid derived ag L and S RNA species and the L and NP
mRNAs. Notably, we observed similar rescue efficiencies
when we used, instead of the Lag and Sag, the corresponding
Lg and Sg constructs. Consistent with this, cell lysates of cells
transfected with genomic or antigenomic L constructs contain-
ing the CAT reporter gene in lieu of the Z ORF, together with
L and NP expressing plasmids, had similar levels of CAT
activity (Fig. 8). This finding indicates that annealing between
viral mRNAs and genome, or antigenome, RNA species do
not appear to pose a significant problem for the rescue of
Arenavirus, which is likely applicable to other ambisense NS
RNA viruses.
A main hurdle for the rescue of LCMV from cDNAs was
to obtain a correct functional IGR. We detected a large
proportion of virion-associated L molecules with an altered
IGR. Whether this finding reflects a biological property of the
virus or a technical issue related to the RT-PCR experimental
procedures used to obtain the L IGR remains to be
determined. Notably, we consistently obtained the correct L
IGR sequence when we used as template for the RT reaction a
RNA generated by in vitro transcription of a plasmid DNA
containing the cDNA of the IGR we (GenBank AY894816)
and others (Grande-Perez et al., 2005) have recently
documented. These results would suggest that Lg and Lag
RNA species with altered IGR sequences are generated in
virus-infected cells and might have functional correlates yet to
be defined. Another obstacle we encountered was to establish
experimental conditions leading to the correct L/S balance
upon amplification by the intracellularly reconstituted LCMV
polymerase. Our initial rescue attempts were based on the use
of an LCMV-specific HR to generate the authentic 3′-termini
of both Lag and Sag RNA species initially synthesized by
T7RP. We found however that although the LCMV-specific
HR was very active when present in the Sag RNA, it
appeared to be mostly inactive in the context of the Lag
RNA. This unexpected finding, specially considering the
sequence similarity between the 3′-termini of the Sag and Lag
RNA species resulted in undetectable levels of Lg RNAderived via replication by the virus polymerase of the T7RP-
mediated input Lag RNA. Only substituting the HDR for the
HR to generate the 3′-end of the L ag RNA could solve this
problem.
Using the same Sag and Lag cDNAs, we have also
established a pol-I/pol-II based rescue of rLCMV (described
elsewhere). In this system, the authentic 5′- and 3′-termini of
both Sag and Lag RNA species were created by the precise
transcription initiation and termination sites of pol-I
(Kawaoka, 2004; Neumann et al., 2002; Pinschewer et al.,
2003a, 2003b). Both the T7RP and pol-I based rescue systems
exhibited similar efficiencies (data not shown). These results
are consistent with the presence of a correct IGR and 3′-
termini sequences in the Lag RNA as key factors for the
successful rescue of LCMV.
The rT7/LCMV differed from LCMV/ARM at the genome
site predicted by the genetic tag introduced into the recombinant
S segment. This genetic difference should not result in
phenotypic differences between these two viruses. Finding
such differences would have suggested that our reverse genetics
approach for the rescue of rT7/LCMV might be prone to
incorporate additional lesions in the viral genome, which would
question its use as a tool for the generation of rLCMV with a
defined genetic makeup for investigation of the Arenavirus
biology. Our results, however, showed that both rT7/LCMVand
LCMV-ARM exhibited the same kinetics and levels of RNA
replication and transcription, as well as similar kinetics and
production peaks of infectious progeny. Likewise, the rT7/
LCMV exhibited all the biological properties predicted for an
ARM-like virus. These results argue against unwanted artifacts
associated with the rescue of infectious LCMV from cDNA, and
support the view that it should be now possible to generate
recombinant LCM viruses with predetermined specific muta-
tions and analyze their phenotypic expression in its natural host,
the mouse. LCMV is an important model to study both acute
and persistent viral infection, as well as virus–host balance and
associated disease, and a variety of basic concepts in
immunology and viral pathogenesis have been developed
using the LCMV model (Buchmeier and Zajac, 1999;
Fig. 5. Induction of lethal LCM upon ic inoculation of mice with rT7/LCMV. B6
mice were injected (ic) with 103 PFU of LCMV-ARM or rT7/LCMV, or with
virus diluent (control). (A) Virus induced mortality. Both LCMV-ARM and rT7/
LCMV induced lethal LCM with the same efficiency, with 100% (N = 8/group)
of the inoculated mice dying at day 7 p.i. (B) Virus titers in brain and serum of
infected mice. Brain homogenates and sera from infected mice were collected at
day 5 p.i. and examined for the presence of infectious virus by plaque assay.
Titers correspond to the average and SD (N = 3/group). (C) Detection of rT7/
LCMV RNA in brain. Brain RNA was isolated from LCMV-ARM and rT7/
LCMV-infected mice at 5 dpi and analyze by RT-PCR to detect the presence of
the genetic tag within the S segment. PCR product derived from RNA isolated
from brain tissue of LCMV-ARM, but not rT7/LCMV, infected mice contained,
as predicted an EcoNI site.
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Zinkernagel, 2002). In addition, LCMV provides investigators
with an excellent system to study basic aspects of the molecular
and cell biology of clinically important human pathogens
including Lassa fever virus (LFV) and other HF arenaviruses.
The ability to generate recombinant LCM viruses with
predetermined specific mutations and analyze their phenotypic
expression in its natural host, the mouse, would significantly
contribute to the elucidation of the molecular mechanisms
underlying LCMV–host interactions including virus persistence
and associated disease.Materials and methods
Cells and viruses
BHK-21 cells were maintained in high-glucose Dulbecco's
Eagle medium (DMEM) supplemented with 10% heat-inacti-
vated (55 °C for 30 min) fetal calf serum (FCS), 2 mM L-
glutamine, 1× tryptose phosphate broth (Life Technologies), 1
mM sodium pyruvate, and 0.5% glucose. Vero E6 cells were
maintained in DMEM supplemented with 10% heat-inactivated
FCS, 2 mM L-glutamine and 10 mM HEPES. Infections with
LCMV were done using a plaque isolate of strain Armstrong
(ARM) (Lee et al., 2000). Virus titers were determined by
plaque assay as described (Dutko and Oldstone, 1983).
Plasmids
Plasmids pC-L, pC-NP, pC-GP expressing the polymerase
(L), nucleoprotein (NP), and glycoprotein (GP) gene products
of LCMV, as well as pC-T7 expressing the T7RP have been
described (Lee et al., 2000, 2002; Perez et al., 2003). Plasmids
pT7-L(+)HR and pT7-S(+)HR allowed for T7 RNA polymerase
(T7RP)-mediated intracellular synthesis of L and S, respective-
ly, antigenomic (ag) RNA species of LCMVARM. The Lag and
Sag sequences in pT7-L(+)HR and pT7-S(+)HR, respectively,
are their 5′- and 3′-termini flanked by a truncated T7RP
promoter, containing a single G, and an LCMV-specific hairpin
ribozyme (HR) (Xing and Whitton, 1992), respectively. The
truncated T7RP promoter permitted the generation by T7RP of
Lag and Sag RNA species containing at their 5′termini the non-
template G characteristically found at the 5′ ends of arenavirus
genomes and antigenomes, whereas self cleavage of the LCMV-
specific HR facilitated the generation of antigenome L and S
RNAs with concert 3′-termini. Plasmid pT7-L(+)HDV was
generated by substituting sequence of the hepatitis delta virus
(HDV) ribozyme for that of the HR to generate the concert 3′-
end of the Lag RNA. To improve the HDV ribozyme self-
processing, we added an extra C residue to the 3′-end of the
plasmid encoded Lag RNA (Perez and de la Torre, 2003;
Perrotta and Been, 1991).
We used a three-way PCR mutagenesis approach to
introduce a genetic tag in to the S segment. This tag involved
a single silent nucleotide substitution to eliminate an EcoNI site
present in the S sequence of ARM.
Primers sequences and detailed protocols used for the
generation of the plasmid constructs are available upon request.
DNA transfection
Cells (2×105/per well) were seeded into 12-well plates, and
transfected with different amount of DNA using lipofectamine
2000 at 2.5 μl/μg DNA.
For rescue of virus, BHK-21 cells were transfected using the
Amaxa nucleofection technology (Amaxa, Koeln, Germany).
Briefly, BHK-21 cells (106 cell per transfection) were
resuspended in 100 μl of solution L (nucleofector kit) and
mixed with cDNA. The mixture was transferred to the provided
Fig. 6. Induction of T-cell responses. Adult B6 mice were injected intraperitoneally with LCMVARM or rT7/LCMV (2 × 105 PFU). Eight days after infection,
spleenocytes were prepared and stimulated for 5 h in vitro with virus specific peptides for NP (aa 396–404), GP (aa 33–41 and aa 61–80). Cells were then stained for
CD8, CD4 and intra-cellular IFN-γ and TNFa. Values in the dot plots indicate the percentage of CD8 and CD4 T cells that were positive for IFN-γ and TNF-a. Both
LCMV-ARM and rT7/LCMV induced similar T-cell responses. Data represent average values (N = 3/group).
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program A-31 with an Amaxa Nucleofector apparatus.
Immediately after nucleofection, cells were transferred into
M6 wells containing pre-warmed 37 °C culture medium.
Detection of viral antigen by indirect immunofluorescence (IF)
Cells were grown onto coverslips placed on the bottom of the
wells of an M24 plate. Cells were washed once with PBS andfixed in acetone/methanol (1:1) for 5 min at room temperature.
After several washes with PBS and a blocking step with 10%
normal goat serum in PBS for 30 min at room temperature, cells
were incubated for 1 h at room temperature with a guinea pig
polyclonal serum to LCMV. After several washes with PBS-
0.1% Triton X-100, samples were incubated for 45 min at room
temperature with a fluorescein isothiocyanate (FITC)-labeled
goat anti-guinea pig immunoglobulin G (IgG). After extensive
washes with PBS-0.1% Triton X-100, coverslips were mounted
Fig. 7. Persistent infection of rT7/LCMV in mice. Newborn B6 mice were inoculated (ic) with rT7/LCMV (103 PFU). (A) Levels of infectious virus were determined
for brain, liver and serum at 21 days p.i. by plaque assay. (B) Viral RNA in brain and liver, and the presence of the genetic tag within the S segment of rT7/LCMV, was
determined by RT-PCR and digestion with EcoNI.
378 A.B. Sánchez, J.C. de la Torre / Virology 350 (2006) 370–380using Mowiol (10% Mowiol (Hoechst), 24% glycerol, 0.1 M
Tris–HCl pH 8.5 and 2.5% 1,4-diazobicyclo{2.2.2}-octane
(DABCO)) (Osborn and Weber, 1982) and analyzed byFig. 8. (A) Schematic of recombinant genome (rLg/CAT) and antigenome (rLag/
CAT) L segments containing the CAT ORF in lieu of the Z ORF. (+) and (−)
refer to the polarity, sense (+) and antisense (−) of the CAT and L ORFs. (B)
CAT activity associated with virus polymerase mediated expression of rLag/
CATand rLag/CATconstructs. BHK-21 cells were transfected with the indicated
combinations of plasmids and 48 h later cell lysates were prepared for CAT
assay. CAT activities were normalized by assigning a value of 100% to the CAT
activity derived from rLg/CAT expression. CAT activity in the absence of pC-L
was below 0.2%. Values correspond to the average and SD of three independent
experiments.fluorescence microscopy. Slides were digitized by using
Adobe Photoshop and Canvas software.
RNA analysis by Northern blotting
RNAwas isolated from cells by using TriReagent (Molecular
Research Center, Cincinnati) according to the manufacturer's
instructions. RNA was analyzed by northern blot hybridization
using 32P-labeled strand specific probes were generated using
appropriated PCR fragments using Lin'Scribe kit (Ambion).
Detection of the genetic tag within the S segment
RNA was isolated from cells and B6 mice brain tissue
infected with either LCMV ARM or rT7/LCMV using
TriReagent (Molecular Research Center, Cincinnati) according
to the manufacturer's instructions. RNAwas reverse transcribed
using SuperScript II RT and random hexamer primers
(Invitrogen), and the corresponding cDNA amplified using
Pfu Turbo polymerase (Stratagene) and specific primers to
amplify a 520 bp NP fragment containing the genetic tag.
Digestion of PCR products distinguish between ARM (EcoNI+)
and rT7/LCMV (EcoNI−) NP derived PCR products.
Mice
Newborn and 8 weeks B6 mice were obtained from the
rodent breeding colony at The Scripps Research Institute (La
Jolla, Calif.). Intracranial inoculation of mice was done as
described (Oldstone et al., 1982).
Flow cytometric analysis
Spleen single-cell suspensions were obtained by homoge-
nizing the spleens through a mesh. Cells were stimulated with
specific peptides from LCMV. Cells were incubated for 10 min
with a rat mAb to CD16/32 to block Fc receptors and then with
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stained for cell surface antigens, using anti-CD8 antibody
conjugated with Pacific Blue (Caltag), anti-CD4 antibody
conjugated with allophycocyanin (APC-Cy7) (BD PharMin-
gen) and anti-CD3 conjugated with peridin chlorophyll protein
(PerCP-Cy5.5) (BD PharMingen), for 20 min on ice in PBS
containing 1% (vol/vol) FBS and 0.1% (wt/vol) NaN3. After,
cells were washed two times, fixed, and permeabilized in 0.1%
(wt/vol) saponin in HBSS. Intracellular cytokine staining was
accomplished with incubation of antibodies to IFN-γ phycoer-
ythrin (PE) and TNFa-fluorescein isothiocyanate (FITC) for 30
min on ice in 0.1% (wt/vol) saponin, 1% FBS PBS, followed by
two washes and resuspension of cells in 1% (vol/vol) FBS,
0.1% (wt/vol) NaN3 PBS, as described (Homann et al., 1998).
Cells were acquired on a Digital LSR II (Becton Dickinson) and
analyzed and FlowJo (Treestar) software.
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